Loading insider details...
Latest Form 4 (Oct 16, 2026): Grant/Award of 20,300 IAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | Grant/Award | 20,300 | n/a |
| Jun 13, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/Award | 3,495 | n/a |
| Mar 14, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/Award | 4,660 | n/a |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 73,731 | n/a |
| Feb 2, 2024 | ENZO BIOCHEM INC (ENZ) | Grant/Award | 79,365 | n/a |